DNLI - Denali Therapeutics GAAP EPS of -$0.68 beats by $0.02
2024-05-07 17:47:39 ET
More on Denali Therapeutics
- Denali: Leveraging Transport Vehicle Technology For Neurological Gains
- Denali spikes after $500M private placement
- Denali slips as Sanofi fails in mid-stage trial for ALS therapy
- Seeking Alpha’s Quant Rating on Denali Therapeutics
- Historical earnings data for Denali Therapeutics